List of low-priced drugs in many places have been announced

Shanghai's 316 low-priced drug species were publicized on Monday evening. At the same time, Henan, Hubei and other provinces were also announced. The list of local low-cost drugs began to enter the “blowout period”.

On May 8th, the National Development and Reform Commission announced the list of low-priced drugs, including more than 1,000 dosage forms containing less than 3 yuan of chemical drugs and less than 5 yuan of Chinese medicines in more than 500 varieties. These varieties will cancel the highest retail prices set by the government. At the same time, the NDRC requires local price authorities to publish a list of low-priced medicines within the pricing range of the current level before July 1. At the NDRC's low price medicine price symposium at the end of May, the head of the price division made it clear that July 1st was the last time cut-off point.

Now that the deadline is approaching, local low-cost drug policies are intensively launched. As of today, 22 provinces and cities, including Hubei, Shanghai and Xinjiang, have actively responded to the policies of the National Development and Reform Commission, including Shanghai, Hubei, Henan, Jilin, Guangdong, Fujian, and Jiangxi. A list of local low-cost drugs was issued in eight provinces in Yunnan.

For the bidding and procurement process, early this month, the Health and Planning Commission proposed only a top-level design, which is to classify low-priced drugs as basic drugs and non-primary drugs to implement classified procurement management. There is still no clear attitude towards how specific low-priced drugs are linked to the Internet. It seems that The problem of landing has been thrown to the place. The NDRC also made it clear at the aforementioned low-cost drug talks that the low-cost drugs were directly linked to the Internet. In view of this, local procurement methods for low-cost drugs are still in the discussion stage. On Tuesday, the person in charge of drug bidding in Shanghai responded to the Great Wisdom News Agency that "the mode of low-cost drug purchase has not yet been decided and will be discussed and discussed in the near future."